![Myrexis, Inc. Logo](/news-release/logo/218223/0/218223.jpg?lastModified=12%2F09%2F2016%2023%3A03%3A24&size=2)
Myrexis to Present at 10th Annual JMP Securities Research Conference
03 mai 2011 16h00 HE
|
Myrexis, Inc.
SALT LAKE CITY, May 3, 2011 (GLOBE NEWSWIRE) -- Myrexis, Inc. (Nasdaq:MYRX), a biotechnology company focused on developing and commercializing novel treatments for cancer, today announced that Adrian...
![Myrexis, Inc. Logo](/news-release/logo/218223/0/218223.jpg?lastModified=12%2F09%2F2016%2023%3A03%3A24&size=2)
Myrexis to Hold Conference Call to Discuss Fiscal Third Quarter 2011 Financial Results
28 avr. 2011 16h00 HE
|
Myrexis, Inc.
SALT LAKE CITY, April 28, 2011 (GLOBE NEWSWIRE) -- Myrexis, Inc. (Nasdaq:MYRX), a biotechnology company focused on developing and commercializing novel treatments for cancer, today announced it will...
![Myrexis, Inc. Logo](/news-release/logo/218223/0/218223.jpg?lastModified=12%2F09%2F2016%2023%3A03%3A24&size=2)
Myrexis Presents Data on Hsp90 Inhibitor Program at 102nd AACR Annual Meeting
05 avr. 2011 08h00 HE
|
Myrexis, Inc.
Potential for Combination With Other Targeted Cancer Therapies
Prodrug With Improved Characteristics Demonstrates Equivalent Efficacy
Evidence of Biological Activity in Patients
SALT LAKE...
![Myrexis, Inc. Logo](/news-release/logo/218223/0/218223.jpg?lastModified=12%2F09%2F2016%2023%3A03%3A24&size=2)
Myrexis Presents Data on Cancer Metabolism Inhibitor Program at 102nd AACR Annual Meeting
05 avr. 2011 08h00 HE
|
Myrexis, Inc.
SALT LAKE CITY, April 5, 2011 (GLOBE NEWSWIRE) -- Myrexis, Inc. (Nasdaq:MYRX), a biotechnology company focused on developing and commercializing novel treatments for cancer, today announced it...
![Myrexis, Inc. Logo](/news-release/logo/218223/0/218223.jpg?lastModified=12%2F09%2F2016%2023%3A03%3A24&size=2)
Myrexis Reorganizes to Align Resources With Current Pipeline
29 mars 2011 12h15 HE
|
Myrexis, Inc.
SALT LAKE CITY, March 29, 2011 (GLOBE NEWSWIRE) -- Myrexis, Inc. (Nasdaq:MYRX), a biotechnology company focused on developing and commercializing novel treatments for cancer, today announced a...
![Myrexis, Inc. Logo](/news-release/logo/218223/0/218223.jpg?lastModified=12%2F09%2F2016%2023%3A03%3A24&size=2)
Myrexis to Provide Update on Heat Shock Protein 90 and Cancer Metabolism Inhibitor Programs at 102nd Annual Meeting of American Association for Cancer Research
17 mars 2011 16h00 HE
|
Myrexis, Inc.
SALT LAKE CITY, March 17, 2011 (GLOBE NEWSWIRE) -- Myrexis, Inc. (Nasdaq:MYRX), a biotechnology company focused on discovering, developing, and commercializing novel treatments for cancer, today...
![Myrexis, Inc. Logo](/news-release/logo/218223/0/218223.jpg?lastModified=12%2F09%2F2016%2023%3A03%3A24&size=2)
Myrexis to Present at 10th Annual Needham Healthcare Conference
16 mars 2011 16h00 HE
|
Myrexis, Inc.
SALT LAKE CITY, March 16, 2011 (GLOBE NEWSWIRE) -- Myrexis, Inc. (Nasdaq:MYRX), a biotechnology company focused on discovering, developing, and commercializing novel treatments for cancer, today...
![Myrexis, Inc. Logo](/news-release/logo/218223/0/218223.jpg?lastModified=12%2F09%2F2016%2023%3A03%3A24&size=2)
Myrexis Reports Second Quarter Fiscal 2011 Financial Results
09 févr. 2011 16h15 HE
|
Myrexis, Inc.
AzixaTM Two-Arm Phase 2b Study in Glioblastoma Initiated
Conference Call Today at 4:30pm EST
Upcoming Events
Report Phase 2 monotherapy results in recurrent glioblastoma multiforme (GBM)...
![Myrexis, Inc. Logo](/news-release/logo/218223/0/218223.jpg?lastModified=12%2F09%2F2016%2023%3A03%3A24&size=2)
Myrexis Announces Azixa(TM) Clinical Data Publications
03 févr. 2011 09h00 HE
|
Myrexis, Inc.
Phase 1 Clinical Data Published by Molecular Cancer Therapeutics
Pre-Clinical, Phase 1 and 2 Clinical Data Review Published by Drugs of the Future
SALT LAKE CITY, Feb. 3, 2011 (GLOBE NEWSWIRE)...
![Myrexis, Inc. Logo](/news-release/logo/218223/0/218223.jpg?lastModified=12%2F09%2F2016%2023%3A03%3A24&size=2)
Myrexis to Hold Conference Call to Discuss Fiscal Second Quarter 2011 Financial Results
01 févr. 2011 09h00 HE
|
Myrexis, Inc.
SALT LAKE CITY, Feb. 1, 2011 (GLOBE NEWSWIRE) -- Myrexis, Inc. (Nasdaq:MYRX), a biotechnology company focused on discovering, developing, and commercializing novel treatments for cancer, today...